Multiple system atrophy (MSA) is a neurodegenerative disorder characterized by autonomic failure (cardiovascular and/or urinary), parkinsonism, cerebellar impairment and corticospinal signs with a median survival of 6-9 years.
This article reports the validation of the German translation of the MSA-QoL.
2
Conclusions: This is the largest study of OH in patients with MSA.
3
Preliminary research on short-term outcomes after MSA demonstrated significant regression of Barrett's.
4
Furthermore, MSA had no effect on this enzyme in all tested tissues.
5
Estimated county-level MSM counts were aggregated to form MSA- and state-level totals.
1
In contrast to AD, NGF receptor-containing cortical neurons were not observed in Parkinson disease, Pick disease, or Shy-Dragersyndrome.
1
All the patients with multiplesystematrophy had hyperreflexia with synergy.
2
A diagnosis of multiplesystematrophy was made, supported by MRI findings and evidence of autonomic dysfunction.
3
Urodynamic findings may be abnormal before patients with multiplesystematrophy reach an advanced stage of the disease.
4
Degenerative processes of disease-specific tracts were clearly identified as illustrated in cases of multiplesystematrophy and Joseph-Machado disease.
5
Objective: To explore the prognostic factors for inability to walk independently in patients with multiplesystematrophy (MSA).
6
We report a 57-year-old woman with multiplesystematrophy (MSA) of 15-month duration.
7
Conclusions: Urodynamic evaluation and sphincter EMG are both useful tests in the differential diagnosis between Parkinson's disease and multiplesystematrophy.
8
Increased age at death was observed in the minimal pathology group, amyotrophic lateral sclerosis, and multiplesystematrophy cases with co-pathologies.
9
Recordings of EMGs from perineal muscles become abnormal as the disease progresses in multiplesystematrophy but not in Parkinson's disease.
10
Our case presented with depression and RBD that preceded parkinsonism, and dysautonomia that led to an initial diagnosis of multiplesystematrophy.
11
A 60-year old man with a 10-year history of multiplesystematrophy (MSA) was found in respiratory arrest.
12
Furthermore, SV2C expression is dramatically altered in postmortem brain tissue from PD cases but not in Alzheimer disease, progressive supranuclear palsy, or multiplesystematrophy.
13
Methods: Sixty two patients (30 with Parkinson's disease and 32 with multiplesystematrophy) underwent a complete urodynamic evaluation and neurophysiological testing.
14
A postmortem examination performed after she was found dead in … We report a 57-year-old woman with multiplesystematrophy (MSA) of 15-month duration.
15
Background: Multiplesystematrophy (MSA) is a rapidly progressive neurodegenerative disorder which causes early sustained disability and quality of life impairment.
16
Multiplesystematrophy (MSA) is a sporadic and rapidly progressive neurodegenerative disorder that presents with autonomic failure in combination with parkinsonism or cerebellar ataxia.